收费全文 | 188174篇 |
免费 | 17666篇 |
国内免费 | 9649篇 |
耳鼻咽喉 | 2357篇 |
儿科学 | 3978篇 |
妇产科学 | 2032篇 |
基础医学 | 33603篇 |
口腔科学 | 5641篇 |
临床医学 | 13989篇 |
内科学 | 24976篇 |
皮肤病学 | 4739篇 |
神经病学 | 11069篇 |
特种医学 | 4091篇 |
外国民族医学 | 146篇 |
外科学 | 15829篇 |
综合类 | 30881篇 |
现状与发展 | 51篇 |
预防医学 | 4907篇 |
眼科学 | 4034篇 |
药学 | 16152篇 |
28篇 | |
中国医学 | 6637篇 |
肿瘤学 | 30349篇 |
2024年 | 342篇 |
2023年 | 2531篇 |
2022年 | 4233篇 |
2021年 | 6697篇 |
2020年 | 5893篇 |
2019年 | 5724篇 |
2018年 | 5844篇 |
2017年 | 6349篇 |
2016年 | 6678篇 |
2015年 | 7726篇 |
2014年 | 10945篇 |
2013年 | 12435篇 |
2012年 | 10786篇 |
2011年 | 12055篇 |
2010年 | 10165篇 |
2009年 | 9707篇 |
2008年 | 10325篇 |
2007年 | 10571篇 |
2006年 | 9703篇 |
2005年 | 8967篇 |
2004年 | 7990篇 |
2003年 | 6979篇 |
2002年 | 5737篇 |
2001年 | 5045篇 |
2000年 | 4127篇 |
1999年 | 3519篇 |
1998年 | 3268篇 |
1997年 | 2887篇 |
1996年 | 2509篇 |
1995年 | 2151篇 |
1994年 | 1866篇 |
1993年 | 1531篇 |
1992年 | 1241篇 |
1991年 | 1174篇 |
1990年 | 898篇 |
1989年 | 847篇 |
1988年 | 789篇 |
1987年 | 630篇 |
1986年 | 585篇 |
1985年 | 776篇 |
1984年 | 689篇 |
1983年 | 483篇 |
1982年 | 506篇 |
1981年 | 401篇 |
1980年 | 340篇 |
1979年 | 253篇 |
1978年 | 178篇 |
1977年 | 138篇 |
1976年 | 103篇 |
1975年 | 39篇 |
Background
Clear cell renal cell carcinoma (ccRCC) is known to occur across the adult lifetime traversing the spectrum of age-related organismal changes. Little is known as to how the aging process may affect the course of renal cell carcinoma (RCC) and the repertoire of genes involved.Methods
Using The Cancer Genome Atlas (n?=?436) and Cancer Genomics of the Kidney (n?=?89) datasets, we applied regression analysis to examine associations between patient age and gene expression profiles in ccRCC tumors and normal kidney tissues. Pathway enrichment analysis was performed to identify cellular process that is affected by aging in ccRCC. Moreover, connectivity mapping analysis was used to predict age-dependent response to drug treatments.Results
Our analysis revealed different age-dependent gene expression spectra in ccRCC and normal kidney tissues. These findings were significant and independently reproducible in both datasets examined. Age up-regulated genes, showing higher expression in older patients, were significantly enriched (false discovery rate <0.05) in normal tissues for pathways associated with immune response and extracellular matrix organization, whereas age up-regulated genes in tumors were enriched for metabolism and oxidation pathways. Strikingly, age down-regulated genes in normal cells were also enriched for metabolism and oxidation, while those in tumors were enriched for extracellular matrix organization. Further in silico analysis of potential drug targets predicted preferential efficacy of Phosphoinositide 3-kinase inhibitor or immunotherapy in association with age.Conclusion
We report on previously unrecognized associations between age and molecular underpinnings of RCC, including age-associated expression of genes implicated in RCC development or treatment. 相似文献Areas covered: This review first focuses on the clinical trials evaluating the efficacy and tolerability of nab-paclitaxel in NSCLC at different settings. The approval of nab-paclitaxel in combination with carboplatin at the front-line setting for advanced NSCLC was based on the key phase III study, which showed that nab-paclitaxel/carboplatin was associated with superior overall response rate and favorable toxicity profile compared to sb-paclitaxel/carboplatin. The review also addresses the nab-paclitaxel pharmacology, other combinations (e.g. immunotherapy with PD-1/PD-L1 inhibitors), potential biomarkers (e.g. caveolin-1), and special subgroups (e.g. the elderly, squamous histology).
Expert opinion: Existing data has established the role of nab-paclitaxel in the management of advanced NSCLC. Emerging evidence, such as preliminary results from Keynote-407 and IMpower 131 studies, indicates that novel combinations of nab-paclitaxel/carboplatin and PD-1/PD-L1 inhibitors could further improve clinical benefits with manageable toxicity. Nevertheless, in order to better position nab-paclitaxel and to improve patient selection, future studies are warranted to further understand its mechanism of action, predictive biomarkers, and potential synergism with other agents. 相似文献